REGENXBIO
RGNX
#7519
Rank
โ‚ฌ0.43 B
Marketcap
6,53ย โ‚ฌ
Share price
-0.28%
Change (1 day)
-36.30%
Change (1 year)

Earnings for REGENXBIO (RGNX)

Earnings in 2026 (TTM): -โ‚ฌ0.12 Billion

According to REGENXBIO's latest financial reports the company's current earnings are โ‚ฌ0.15 Billion. In 2025 the company made an earning of -โ‚ฌ0.14 Billion, an increase over its 2024 earnings that were of -โ‚ฌ0.2 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for REGENXBIO from 2015 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ0.12 Billion-11.85%
2025 -โ‚ฌ0.14 Billion-30.58%
2024 -โ‚ฌ0.2 Billion-16.49%
2023 -โ‚ฌ0.24 Billion-0.14%
2022 -โ‚ฌ0.24 Billion-253.5%
2021 โ‚ฌ0.15 B-259.29%
2020 -โ‚ฌ95.88 Million-29.42%
2019 -โ‚ฌ0.14 Billion-269.12%
2018 โ‚ฌ80.31 M-216.1%
2017 -โ‚ฌ69.18 Million19.69%
2016 -โ‚ฌ57.8 Million178.03%
2015 -โ‚ฌ20.79 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-โ‚ฌ0.15 Billion 12.34%๐Ÿ‡บ๐Ÿ‡ธ USA